TREATMENT OF ADVANCED MEDULLARY-THYROID CANCER WITH AN ALTERNATING COMBINATION OF 5-FU-STREPTOZOCIN AND 5-FU-DACARBAZINE

被引：85
作者：
SCHLUMBERGER, M
ABDELMOUMENE, N
DELISLE, MJ
COUETTE, JE
机构：
[1] INST JEAN GODINOI, F-51000 REIMS, FRANCE
[2] INST FRANCOIS BACLESSE, F-14000 CAEN, FRANCE
来源：
BRITISH JOURNAL OF CANCER | 1995年 / 71卷 / 02期
关键词：
CHEMOTHERAPY; MEDULLARY THYROID CARCINOMA;
D O I：
10.1038/bjc.1995.73
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Combinations of 5-fluorouracil (5-FU) and streptozocin and 5-FU and dacarbazine were given alternately to 20 patients with metastatic medullary thyroid carcinoma. Three partial responses and 11 long-term stabilizations were observed. No unexpected toxicity occurred.
引用
收藏
页码：363 / 365
页数：3
相关论文
共 22 条
[1]   CHEMOTHERAPY IN METASTATIC NONANAPLASTIC THYROID-CANCER - EXPERIENCE AT THE INSTITUT-GUSTAVE-ROUSSY [J].
DROZ, JP ;
SCHLUMBERGER, M ;
ROUGIER, P ;
GHOSN, M ;
GARDET, P ;
PARMENTIER, C .
TUMORI, 1990, 76 (05) :480-483
[2]  
GOTTLIEB JA, 1975, CANCER CHEMOTH REP 3, V6, P283
[3]   CHEMOTHERAPY FOR THYROID-CANCER [J].
HOSKIN, PJ ;
HARMER, C .
RADIOTHERAPY AND ONCOLOGY, 1987, 10 (03) :187-194
[4]   FAILURE OF MEDULLARY CARCINOMA OF THYROID TO RESPOND TO DOXORUBICIN THERAPY [J].
HUSAIN, M ;
ALSEVER, RN ;
LOCK, JP ;
GEORGE, WF ;
KATZ, FH .
HORMONE RESEARCH, 1978, 9 (01) :22-25
[5]  
KELSON DP, 1982, P ASS CANCER RES, V13, P111
[6]  
KESSINGER A, 1983, CANCER, V51, P790, DOI 10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO
[7]  
2-3
[8]   LONG-TERM TREATMENT OF METASTATIC MEDULLARY-THYROID CARCINOMA WITH THE SOMATOSTATIN ANALOG OCTREOTIDE [J].
MAHLER, C ;
VERHELST, J ;
DELONGUEVILLE, M ;
HARRIS, A .
CLINICAL ENDOCRINOLOGY, 1990, 33 (02) :261-269
[9]  
MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[10]  
2-6
123